Benzo [a]pyrene (BaP) is a ubiquitous environmental contaminant that is both an endocrine disruptor and a carcinogen. Aromatase (CYP19) is a key enzyme in steroidogenesis that is responsible for conversion of androgens to estrogens and thus plays a key role in steroid homeostasis. We hypothesized that some of the adverse outcomes of early developmental exposure to BaP are the result of reduced Cyp19a1b activity. Our goal was to investigate the role of estrogen homeostasis during early development and determine the role of aromatase inhibition as a relevant mechanism in BaP's developmental toxicities. One-cell zebrafish embryos were injected with a Cyp19a1b-morpholino (MO) or control-MO. Other non-injected embryos were exposed to waterborne BaP, fadrozole (a Cyp19 inhibitor), estradiol (E2), BaP þ E2, Cyp19a1b MO þ E2, or fadrozole þ E2 for 96 hours post-fertilization (hpf). Adverse outcomes were compared between treatments, and the ability of E2 co-exposure to rescue each observed dysmorphology was assessed. BaP significantly decreased cyp19a1b gene expression in 96 hpf zebrafish larvae homogenates. Concentrations of E2 in 48 hpf larvae were significantly decreased by BaP, fadrozole and Cyp19a1b-MO. Cumulative mortality of zebrafish larvae was significantly increased following BaP or fadrozole exposure or Cyp19a1b knockdown compared to controls. E2 co-treatment rescued mortality caused by 10 lg/L BaP, 10 lg/L fadrozole, or Cyp19a1b-MO. In a treatment-blinded morphological assessment of larvae at 96 hpf, several phenotypes were negatively impacted by BaP, fadrozole, or Cyp19a1b knockdown and rescued by exogenous E2 co-treatment; these included body length, optic vesicle size, swim bladder inflation, pericardial and abdominal edema, and incidence of normal larval tail shape. Abnormal pectoral fins were caused by BaP exposure only. Uninflated swim bladders were caused by all treatments including E2 alone. Our results indicate that certain BaP-mediated adverse developmental outcomes were mechanistically in accordance with BaP-mediated Cyp19a1b inhibition.
low birth weights (Duarte-Salles et al., 2013; Siddiqui et al., 2008) and cleft lip 6 palate (Langlois et al., 2013) . Additionally, PAHmediated birth-length deficit was persistent in children and associated with decreased height at age 9 after prenatal PAH exposures above 34.7 ng/m 3 (Jedrychowski et al., 2015) . Similar adverse developmental outcomes following BaP prenatal exposures occur in laboratory animal models including decreased fetal survival (Archibong et al., 2002) , low birth weight, and developmental abnormalities (Barbieri et al., 1986; Legraverend et al., 1984) . Fish models specifically have been useful in establishing a suite of PAH-mediated developmental deformities including cardiac toxicity, morphological deformities and growth suppression caused by PAHs. These adverse phenotypes have been interrogated based on, for example, number of aromatic rings (Incardona et al., 2004 (Incardona et al., , 2006 (Incardona et al., , 2011 , dependence of aryl hydrocarbon receptor (AhR) activation and/or CYP1 inhibition in the mechanism of action (Billiard et al., 2006; Brown et al., 2015; Goodale et al., 2013; Jayasundara et al., 2015) , and oxidation state of the PAHs (Goodale et al., 2015) . Because BaP binds to the AhR and activates its own metabolic pathway via CYP1 biotransformation, the AhR clearly has an important well established role in BaP-mediated adverse outcomes. BaP is also a recognized endocrine disrupting compound. Our previous work in Fundulus heteroclitus found that BaPwaterborne exposure inhibited both adult and embryo brain aromatase expression (Dong et al., 2008) . Also, waterborne BaP exposure of Fundulus caused significantly decreased testosterone concentrations and testis weights in males, decreased estradiol concentrations in females and significantly altered egg fertilization (Booc et al., 2014) . Aromatase, which is encoded by the CYP19 gene, is responsible for the conversion of C19 androgens (typically testosterone and androstenedione) to C18 estrogens. All mammals, with the exception of pigs, have a single form of the CYP19 gene, and tissue specificity in aromatase gene regulation is due to alternative promoter splicing (Santen et al., 2009) . In fish, there are two separate and distinct CYP19 loci that encode for two isoforms, namely, cyp19a1a (predominantly expressed in the gonad and not estrogen inducible) and cyp19a1b (predominantly expressed in the brain and induced by estrogens) (Callard et al., 2001; Sawyer et al., 2006) . Maintenance of aromatase activity and estrogen homeostasis is key in both normal physiology and disease etiologies including reproduction, development, behavior, and carcinogenesis (Blakemore and Naftolin, 2016) . Estrogen receptor signaling and the role of estrogen in early development are highly conserved across vertebrates (Bondesson et al., 2015) . Endocrine-disrupting chemicals (EDCs) interfere with tissue-specific steroid hormone homeostasis through many complex and interrelated molecular pathways (Sanderson, 2006; Zoeller et al., 2012) . Specifically, EDC-mediated aromatase inhibition by letrozole caused postimplantation loss and vertebral anomalies following gestational exposure in rats (Tiboni et al., 2008) while embryonic exposure to the aromatase inhibitor formestane causes cardiovascular failure in zebrafish (Allgood,Jr et al., 2013) .
In zebrafish, our work and others' have established that either parental or embryo/larval exposure to BaP causes dosedependent decreased survival, cardiac and yolk sac edemas, and morphological defects (Corrales et al., 2014; Incardona et al., 2011) . To further predict BaP's various mechanisms of developmental toxicity, we conducted pathway analysis on differentially expressed genes following a parental and continuous developmental waterborne BaP exposure of zebrafish. Disease pathways predicted by Ingenuity Pathway Analysis were consistent with BaP developmental toxicities, and importantly the estrogen biosynthesis pathway was one of the top significantly altered canonical pathways (Fang et al., 2015) . Thus, our goal here was to assess the impact of reduced aromatase activity in early development by comparing morpholino-mediated transient knockdown, pharmacological/toxicological inhibition (fadrozole and BaP) and phenotypic rescue with exogenous estradiol treatment. We hypothesized that reduced Cyp19a1b activity contributes to BaP's developmental adverse outcomes.
METHODS
Zebrafish culture. Fli-EGFP transgenic zebrafish were kindly provided by Dr. Tanguay (OSU) and were raised under IACUCapproved conditions. Fish were kept in Aquatic Habitats ZF0601 Zebrafish Stand-Alone Systems (Aquatic Habitats, Apopka, Florida) with zebrafish water (pH 7.0-7.5, 60 parts per million (ppm) Instant Ocean, Cincinnati, OH) at 24-30 C, 14:10 light-dark cycle. Adult fish were fed twice daily with TetraMin V R Tropical Flakes (Pentair AES, Apopka, Florida) and live brine shrimp. Larvae were fed with ArteMac-0 powdered food (20-80 lm size, Bio-Marine, Hawthorne, California) and/or live brine shrimp depending on their age. Sexually mature fish were selected as breeders and their eggs were collected for the studies.
Embryo waterborne exposures. Fertilized eggs were cleaned and disinfected with 0.4 ppm methylene blue for 1-2 min and then randomly sorted into ten treatment groups (4-8 replicates per group), namely control dimethylsulfoxide (DMSO, 0.01% v/v), 17b-estradiol (E2; 10 nM, 2.72 lg/L), 10 lg/L (40 nM) or 50 lg/L (200 nM) BaP (stock solution 0.5mg/mL in DMSO), 10 (38.5 nM) or 50 lg/L (193 nM) fadrozole (Sigma-Aldrich, stock solution 0.5mg/ mL in DMSO; final DMSO concentration was 0.01% in all treatment groups), 10 BaP þ E2, 50 BaP þ E2, 10 fadrozole þ E2, or 50 fadrozoleþ E2. Fifty fertilized eggs per treatment group were pooled randomly and raised in 50 mL of zebrafish water in glass petri dishes. During the exposure period (2.5-96 hpf), 0.4 ppm methylene blue was added to the exposure solutions to inhibit fungus growth. Water was changed and embryos were re-dosed daily. BaP concentrations in the water extracts (4 replicates/treatment) were measured by gas chromatography (Agilent 6890, Agilent Technologies, Santa Clara, California) coupled with mass spectrometry (Agilent 5973N). Actual BaP concentrations were 7.6 6 1.19 mg/L (for 10 mg/L), and 37.5 6 2.15 mg/L (for 50 mg/L). BaP concentrations were selected to be below the reported EC 50 of developmental toxicity (Weigt et al., 2011) and to have impacted cyp19a1b expression in fish (Dong et al., 2008) . Larvae were pooled in 0.5 mL RNAlater (15 larvae/pool, 3 replicates/treatment) at 96 hpf for RNA extraction and stored at À80 C.
RNA extraction, purification and reverse transcription. (Corrales et al., 2014) . Feature analysis included body length, optic vesicle, heart, swim bladder, abdomen, and craniofacial morphology. Blind to treatment measurements and scoring of the anatomical structures were recorded using ImageJ software (Schneider et al., 2012) . Scoring criteria for tail and pectoral fin assessments were assigned following specific measures described in Supplementary Table 2 .
Sample preparations and HPLC quantitation of estrogen concentrations. Non-exposed zebrafish embryos were collected at 4, 48, and 72 hpf. Also, exposed embryos, either to BaP (10 and 50 mg/L), fadrozole (50 mg/L), or injected with control-MO or Cyp19a1b-MO were collected at 48 hpf (n ¼ 3, 25 embryos/pool). Embryos/larvae were washed with deionized water 3 times then sorted in 1.5 mL ultra-centrifuge epitubes. Water was completely removed, and 0.5 mL of 0.2 N perchloric acid (SigmaAldrich) was added. Then embryos/larvae were homogenized on ice for 3 cycles (each cycle consisted of 10 s homogenization followed by 10 s rest), and sonicated for 20 min (Branson, 3510) . After centrifugation at 98 400 Â g for 30 min at 23 C using an Optima Max Ultracentrifuge (Beckman Coulter), the supernatant was transferred to a test tube and an additional 0.5 mL of 0.2 N perchloric acid was added. Two additional extractions were performed as described. All combined supernatants were evaporated to dryness using a stream of nitrogen gas at 45 C in a water bath. The dried residue was reconstituted in 100 mL of the mobile phase consisting of HPLC grade acetonitrile:water (40:60% v/v). For sample cleanup, a Waters HPLC system consisting of 717 plus autosampler, 600 pump, and 2489 UV detector, and Empower 3 software was used. A volume of 96 mL of each sample was injected onto a C18 column (100 mm length, 4.6 mm diameter, and 3 mm particle size, Phenomenex # 00D-0075-E0) using a 0.6 mL/min flow rate and a 15 min run time.
The wavelength of UV detector was 280 nm. The eluent was collected manually 1 min before the retention time of the E2 standard peak and 2 min after for each sample. This eluent was dried and then reconstituted with 60 mL of mobile phase (HPLC grade acetonitrile:water (50:50% v/v)). For E2 quantitation, a Waters HPLC system with a 2475 fluorescent detector was used (280 nm:310 nm for excitation:emission wavelengths, 30 nm for gain, and 600 nm for EUFS). Detection of E2 concentrations was done by injecting 50 mL of cleaned-up sample onto a C18 column (150 mm length, 4.6 mm diameter, and 3 mm particle size, Phenomenex # 00F-4311-E0) at 0.6 mL/min flow rate and a 14 min run time. The retention time of E2 was 8.479 6 0.130 min. The external standard curve of known E2 concentrations ranged from 2.344 to 300 nM and was analyzed as described above. To verify the recovery of E2 during the clean-up method, a 225 nM stock of E2 was processed as described. The E2 recoveries (n ¼ 3) for E2 during sample clean-up were 95.8 6 1.23%.
Statistics. Results were analyzed using GraphPad Prism 5.0 (La Jolla, California) and presented as mean 6 S.E. Mortality, hatching, RT-qPCR, and data of developmental deformities were analyzed using the 1-way ANOVA followed by Newman-Keuls post hoc test. Deformity incidence by treatment across score classifications was analyzed by 2-way ANOVA. Statistical significance was accepted at P .05.
RESULTS
cyp19a1b and cyp1a Gene Expression RT-qPCR results indicated that 10 and 50 lg/L BaP significantly decreased cyp19a1b expression by 38 and 40 percent, respectively compared to DMSO control-treated larvae at 96 hpf (ANOVA, n ¼ 3 replicates/treatment, 15 larvae/pool; P < .05; Supplementary  Fig. S2 ). In contrast at 48 hpf, cyp19a1b expression was neither significantly reduced relative to control by BaP nor induced by E2 (10nM) (Supplementary Fig. S3A ). Furthermore, in 48 hpf larvae exposed to 50 lg/L BaP þ E2 and 50 lg/L fadrozole þ E2, cyp19a1b expression was induced relative to control. As an indication of AhR activation, cyp1a expression was also measured at 48 hpf. BaP dose-dependently increased cyp1a expression and cotreatment with 10 lg/L BaP þ E2 caused significantly higher induction than 10 lg/L BaP alone ( Supplementary Fig. S3B ).
Hatching Efficiency and Mortality of Zebrafish Embryos/Larvae
Compared to DMSO controls at 48 hpf, hatching efficiency was significantly decreased in 10 and 50 lg/L BaP treated larvae with or without E2 co-exposure ( Fig. 2A) . However, by 72 hpf no significant decrease remained in hatching efficiency in BaP treated groups (data not shown). In the fadrozole experiment, the percentage of hatched larvae significantly decreased from 69% in the control group to 2%, 4%, 11%, and 2% by 10, 50 lg/L fadrozole and 10 fadrozole þ E2, 50 fadrozole þ E2, respectively at 48 hpf ( Fig. 2A) . Again, by 72 hpf percent hatch statistically recovered to control levels in all but the 10 lg/L fadrozole treatment group (97%) (data not shown). At 48 hpf, Cyp19a1b-MO significantly decreased the percent of hatched larvae from 84% in control-MO group to 35% ( Fig. 2A) . Cyp19a1b morphants that were treated with E2 hatched similar to controls. At 72 hpf, there was no significant change in hatching percentage by any of the treatments. Thus, regardless of the mechanism by which Cyp19 was inhibited, delayed hatch was only observed at the early (48 hpf) time point, estrogen treatment did not restore the decreased hatch caused by BaP or fadrozole at 48 hpf, but by 72 hpf all of the treatment groups were insensitive to differences in hatching efficiency. Increased mortality was detected in zebrafish embryos/larvae exposed to BaP (10 and 50 lg/L) alone or BaP þ E2 (10 nM) ( Fig. 2B ; 96 hpf shown). Co-treatment of 10 nM E2 nonsignificantly decreased the mortality caused by 10 BaP, but the highest mortality was in the 50 BaP þ E2 treatment group. At all assessed time points (24, 48, 72, and 96) , mortality of embryos/ larvae was significantly increased by 10 and 50 lg/L fadrozole compared to control (Fig. 2B) . Mortality caused by 10 lg/L fadrozole was significantly rescued by E2 co-treatment. In contrast, 50 fadrozole þ E2 significantly enhanced mortality to 11% compared to just 5% in 50 lg/L fadrozole alone. Embryo/larval mortality significantly increased from around 20% in control-MO groups to about 40% in the Cyp19a1b-MO at all-time points (Fig. 2B ). E2 co-treatment significantly decreased the mortality mediated by Cyp19a1b knockdown.
Morphological Changes in 96 hpf Zebrafish Larvae
Body length of 96 hpf larvae was significantly decreased from 3.68 6 0.043 mm in the control group to 3.26 6 0.089 mm and 2.79 6 0.09 mm by 10 and 50 mg/L BaP, respectively ( Fig. 3A ; Supplementary Fig. S4 ). While decreased body length caused by the lower BaP dose was restored by E2 co-exposure, the 50 lg/L BaP þ E2 did not rescue the decreased body length mediated by 50 lg/L BaP alone. Both 10 and 50 lg/L fadrozole significantly decreased larval body length from 3.76 6 0.0204 mm in the control group to 3.34 6 0.04 and 3.20 6 0.12 mm, respectively. E2 cotreatment significantly restored the decrease in larval body length mediated by both 10 and 50 lg/L fadrozole. Cyp19a1b-MO also significantly decreased larval body length to 3.31 6 0.06 mm from 3.93 6 0.07 mm in the control-MO group, and E2 cotreatment significantly restored the decreased larval body length in Cyp19a1b morphants to the length of the E2 alone treatment.
Optic vesicle (eye) area ( in Cyp19a1b morphants. The Cyp19a1b-MO þ E2 treatment significantly counteracted the reduction in larval optic vesicle area.
Control larvae had swim bladders with average areas of 0.024 6 0.01 mm groups, 100% of the larvae had uninflated swim bladders (Fig.  3C ). E2 treatment alone also caused a decreased swim bladder area, with 15 of the 20 larvae having uninflated swim bladders. One hundred percent of the 10 and 50 lg/L fadrozole-treated larvae had uninflated swim bladders. The swim bladder area was significantly increased by fadrozole þ E2 co-treatments but not to the area of controls. In the 10 nM E2, Cyp19a1b-MO and Cyp19a1b-MO þE2 treatment groups uninflated larval swim bladders were also observed.
BaP (10 and 50 mg/L), fadrozole (10 and 50 mg/L) and Cyp19a1b morphants significantly increased both pericardial edema (0.0191 6 0.004, 0.0181 6 0.001, 0.0199 6 0.008, 0.025 6 0.005 and 0.062 6 0.018 mm 2 , respectively, Fig. 3D ) and yolk sac edema (0.0371 6 0.009, 0.0658 6 0.009, 0.035 6 0.012, 0.043 6 0.005, and 0.084 6 0.0264 mm 2 , respectively, Fig. 3E ). Co-exposure to E2 significantly reduced both pericardial and yolk sac edemas in all treatment groups except for the 50 lg/L BaP þ E2 treatment.
Blind to treatment scoring of larval tail shape showed that incidence of normal tail shape significantly decreased from 95% in the control group to 20% in the 50 lg/L BaP and 50 BaP þ E2 (Fig. 4A) . The mild tail deformity category was significantly increased by 50 BaP and 50 BaP þ E2, while the moderate tail deformity incidence was significantly increased by only 50 BaP þ E2. Incidence of normal tail shape was decreased from 90% in the controls to 45% and 50% by 10 and 50 lg/L fadrozole, respectively (Fig. 4C) . Estradiol co-treatment significantly counteracted the reduction of normal tail shape mediated by fadrozole treatments. Incidence of normal tail shape was significantly decreased from 80% in the control-MO group to 25% by Cyp19a1b-MO (Fig. 4E) . Also, Cyp19a1b morphants had significantly increased incidence of severe tail shape deformities compared to the control-MO group. In Cyp19a1b morphants co-treated with E2, no significant reduction in normal tail shape was noted. In scoring of pectoral fin shape, both BaP concentrations significantly decreased incidence of normal pectoral fin from 90% in control group to 50% and 0%, respectively (Fig. 4B) . Both moderate and severe pectoral fin deformity incidence were significantly increased by 50 lg/L BaP. BaP þ E2 cotreatment provided no rescue of fin deformities. There were no significant changes in pectoral fin shape observed in either fadrozole (Fig. 4D ) or Cyp19a1b morphant (Fig. 4F ) treatment groups.
FIG. 2.
Hatching efficiency at 48 hpf (A) and cumulative mortality at 96 hpf (B) of zebrafish larvae exposed to waterborne BaP 10 or 50 lg/L, fadrozole 10 or 50 lg/L and Cyp19a1b knockdown with or without 10 nM E2 co-treatment. Within experiment, bars with different letters are significantly different (ANOVA; n ¼ 4 replicates/treatment, 50 larvae/pool; P < .05). At 24 hpf, 10 and 50 BaP as well as 50 BaP þ E2 significantly increased mortality compared to controls (data not shown).
FIG. 3.
Morphological changes in larvae caused by BaP, fadrozole and Cyp19a1b knockdown 610 nM E2 at 96 hpf. Body length (A), optic vesicle (B), swim bladder (C), pericardial (D) and yolk sac (E) edemas using ImageJ. Bars with different letters were significantly different (ANOVA, n ¼ 4 replicates/treatment, 50 larvae/pool, P < .05).
Effects of BaP, Fadrozole, and Cyp19a1b Knockdown on Estrogen Concentrations in Zebrafish Embryos
Embryo/larval estradiol concentrations significantly increased during development in a time-dependent manner from 78.57 6 4.08 pg/embryo at 4 hpf to 137 6 6.55, and 170 6 9.31 pg/ larvae at 48 and 72 hpf, respectively (Fig. 5A) . Estradiol concentrations at 48 hpf in control groups (137 6 6.55 and 131 6 4.23 pg/ embryo in control-DMSO and control-MO, respectively) were significantly decreased to 66.7 6 10.8, 86.0 6 19.0, 77.4 6 14.5, and 57.2 6 0.51 pg/embryo by 10 BaP, 50 BaP, 50 lg/L fadrozole, and Cyp19a1b-MO, respectively (Fig. 5B ).
DISCUSSION
Our experimental goal was to investigate BaP-mediated reduction in Cyp19a1b activity as a key event in the specific developmental toxicities manifested by early life BaP exposure. It is well established that steroidogenesis is highly conserved in vertebrates, and estrogen homeostasis, controlled in part via aromatase, is key in diverse biological functions including reproduction, behavior and memory, bone density and vascular homeostasis (Blakemore and Naftolin, 2016) . Estrogen signaling is critical during embryo development for survival, brain development (Bondesson et al., 2015) , normal sex differentiation (Muth-Kohne et al., 2016) and cardiovascular system formation (Allgood,Jr et al., 2013) . The focus of this study was on brain aromatase expressed by cyp19a1b. Teleosts are unique from most mammals because they express two distinct aromatase genes, one that is primarily expressed in the brain and one that is primarily expressed in the gonad. Yet when nucleotide sequences are compared, little functional divergence among vertebrate aromatases suggests similar functionality, though transcription of these genes can be highly variable (Wilson et al., 2005) . In fish, brain aromatase activity, localized in radial glial cells, is much higher compared to expression in the fish gonad or in mammalian brains (Callard et al., 2001; Vosges et al., 2010) . Because cyp19a1b expression is highly inducible by estrogenic compounds, its expression is widely used as a biomarker for environmental EDCs (Fetter et al., 2014) .
With respect to BaP's ability to disrupt aromatase gene expression and activity, initial RT-qPCR studies using Fundulus heteroclitus, an outbred estuarine fish, showed no significant effect on cyp19a1b expression in either BaP-exposed adults or embryos which was attributed to high inter-fish variability (Patel et al., 2006) . In contrast, in situ hybridization showed that BaP significantly decreased cyp19a1b expression in both Fundulus adults and embryos (Dong et al., 2008) . Similarly, in this study both 10 and 50 lg/L BaP significantly reduced cyp19a1b expression at 96 hpf, but not 48 hpf, in zebrafish larvae.
BaP is lethal and teratogenic to zebrafish embryos with LC 50 of 5.1 mM (1285 mg/L) and an EC 50 of 0.52 mM (131 mg/L), respectively (Weigt et al., 2011) . Our previous work showed that environmentally relevant concentrations of 2.4 and 24 mg/L BaP increased the larval mortality to 38.5% and 25%, respectively, compared to control (Fang et al., 2013) . In this study, both 10 and 50 mg/L nominal BaP concentrations increased the mortality by 7.5% and 21%, respectively. The mortality typically increased within the first 24 hpf, and then remained stable until 72 hpf. The potential role for Cyp19a1b to be a mediating factor in survival was shown by the fact that Cyp19a1b knockdown and both aromatase inhibitor doses (10 and 50 mg/L fadrozole) also significantly increased mortality of zebrafish embryos and larvae at all time points compared to control groups. This finding was consistent with other studies that reported increased mortality of zebrafish larvae that were exposed to aromatase inhibitors including fadrozole (Allgood,Jr et al., 2013; Santos et al., 2014) . With HPLC analyses, it was confirmed that all 3 mechanisms of aromatase inhibition decreased E2 concentrations in 48 hpf larvae by 43-63% (Fig. 5B) . Furthermore, the essentiality of estrogen homeostasis during early development was proven because co-treating embryos/larvae with 10 nM E2 decreased mortality mediated by 10 mg/L BaP, 10 mg/L fadrozole and Cyp19a1b-MO knockdown.
While E2 was able to rescue mortalities associated with the low BaP and fadrozole concentrations, the 50 mg/L BaP þ E2 and 50 mg/L fadrozole þ E2 co-treatments significantly increased the mortality of zebrafish embryos and larvae compared to the mortality caused by either of the high doses of BaP or fadrozole alone. BaP is a ligand of aryl hydrocarbon receptor (AhR), which is a member of the basic-helix-loop-helix Per (Period)-ARNT (aryl hydrocarbon nuclear translocator)-SIM (single minded) (bHLH-PAS) family. After activation by ligands like BaP or TCDD, AhR binds ARNT and associates with AhR response elements (XRE) on the target genes, such as CYP1A1 and CYP1B1 (MuleroNavarro and Fernandez-Salguero, 2016). In 96 hpf zebrafish exposed prenatally and developmentally to waterborne BaP, cyp1 induction is linked to BaP's carcinogenicity and teratogenicity disease pathways (Fang et al., 2015) . However, it is also established that CYP1A1 and CYP1B1 enzymes can metabolize E2 (Lee et al., 2003) , and this is one of the proposed mechanisms in the cross-talk between AhR and ER pathways (Matthews and Gustafsson, 2006) . In fact, the larval E2 concentrations were decreased in BaP compared to control 48 hpf larvae in this study potentially both from enhanced metabolism of the E2 by induced Cyp1a and the inhibition of Cyp19a1b.
AhR-ER cross-talk also occurs because some E2-induced genes are inhibited by activation of AhR (reviewed in: (Safe and Wormke, 2003) . The zebrafish cyp19a1b promoter has an ERE which mediates upregulation by E2, but it also has an AhR recognition site (Tong and Chung, 2003) . A recent study specifically evaluated the cross-talk between the AhR and ER pathways in goldfish by measuring the effects of E2, BaP, and the combination of BaP þ E2 on the expression of ahr2, ERa, and cyp1a as well as circulating vitellogenin concentrations and CYP1-enzyme activity. BaP induced ahr2 and cyp1a in a dosedependent manner but antiestrogenic activity was noted in E2 þ lower concentrations of BaP (20 and 50 lg/L) reflected by inhibited ahr2 and cyp1a expression and a decrease in vitellogenin concentrations and thus, a 'reciprocal inhibiting mode of ER-AhR interaction' was suggested (Yan et al., 2012) . Similarly, we found the phenotypic effects caused by the lower concentrations of BaP were rescued by E2 treatment, whereas the higher doses in co-treatment often showed enhanced toxicity further supporting the potential for AhR and ER cross-talk. Yet, in our study cyp1a expression in BaP þ E2 co-treated 48 hpf larvae was not inhibited but rather significantly increased in the 10 lg/L BaP þ E2 relative to 10 lg/L BaP alone. The specific molecular interactions between signaling pathways and steroid concentrations at key developmental stages are still not proven to explain the dose-dependence of E2 rescue of low but not high dose BaP or fadrozole mortality.
Normally, zebrafish embryos start to hatch out of the chorion between 48 and 72 hpf (Kimmel et al., 1995) . Waterborne exposure to both low and high BaP doses significantly increased hatching time compared to control (at 48 hpf) which was consistent with a previous study (Fang et al., 2013) . Also, fadrozole exposure and knockdown of Cyp19a1b significantly increased time to hatch. Although this study did not assess the effects of BaP, fadrozole, and Cyp19a1b on specific molecular or physical hatching-associated mechanisms, it is hypothesized that because of general reduced fitness (reflected in decreased length, edemas, body and fin axis defects) that the delayed hatching could be due to decreased contractile movements. Delayed development and fitness of zebrafish embryos has been suggested to account for alterations in hatching period (Danzmann et al., 1989) . Importantly, by 72 hpf all treatment groups completely hatched so the overall impact of delayed hatch may not be physiologically significant.
In addition to mortality, 6 developmental phenotypes were negatively impacted by BaP and fadrozole waterborne exposure and Cyp19a1b knockdown in 96 hpf zebrafish larvae including: body length; incidence of normal larval tail; optic vesicle; swim bladder inflation as well as causing pericardial and abdominal edema. Many of these phenotypes were consistent with those reported in humans and model organisms following exposure to PAHs and/or BaP.
One of the most recognized AhR-mediated toxicities of halogenated aryl hydrocarbon (HAH) and PAH embryonic exposure is cardiotoxicity (Brown et al., 2015; Incardona et al., 2011; Plavicki et al., 2013) . Epidemiological studies have linked maternal smoking and infant congenital heart defects (Alverson et al., 2011) . Likewise, many studies have reported an increased risk of ischemic heart disease and cardiovascular mortality due to cardiovascular disease in employees who are occupationally exposed to high concentrations of PAHs (Burstyn et al., 2005) . Both BaP concentrations significantly caused pericardial edema in zebrafish larvae. It is well established that BaP exerts its cardiotoxicities through induction of CYP1A via AhR2 (Incardona et al., 2011) . That said, the critical role of Cyp19a1b expression for estrogen synthesis during cardiac development has been highlighted with the 'listless' model wherein zebrafish are exposed to the aromatase inhibitor 4-hydroxy androstenedione during early development (Nelson et al., 2008) . In the listless model, E2 replacement rescued cardiac abnormalities, restored heart function and size and normalized vascular defects (Allgood,Jr et al., 2013) . Similar to BaP exposure, we found that fadrozole and Cyp19a1b knockdown caused significant pericardial edema. In fact, additional studies with the listless model have highlighted the interdependence of multiple phenotypes subsequent to developmental aromatase inhibition including decreased larval trunk muscles because of neuromuscular denervation (Houser et al., 2011) , curved body axes and mortality due to cardiac arrest (Nelson et al., 2008) . Therefore, developmental aromatase inhibition via toxicological, pharmacological or knockdown causes a diverse suite of adverse outcomes, but it is currently unknown how each specific toxicity interacts in the continuum of developmental toxicity and/or if effects are all downstream of initial cardiovascular insult.
For example, disproportionate fetal growth is, in turn, related to coronary heart disease (Barker, 1997) . Human epidemiological studies suggest that when comparing offspring of smoking and non-smoking mothers, babies of smoking moms have significantly lower birth lengths (Prabhu et al., 2010; Vardavas et al., 2010; Wang et al., 1997) . Furthermore, studies of fetal exposure to PAH via ambient pollution has found that newborns had a significantly decreased birth-length (Perera et al., 1998 (Perera et al., , 2003 , and this birth-length deficiency persisted into their childhood (Jedrychowski et al., 2015) . In fish, BaP significantly decreased length of seabass (Dicentrarchus labrax) juveniles (Gravato and Guilhermino, 2016) . Also, decrease in body length was one of the phenotypes that resulted after zebrafish parental dietary BaP exposure in F1 generation (Corrales et al., 2014) . Here, we found that both BaP and fadrozole waterborne exposure and Cyp19a1b knockdown significantly decreased zebrafish larvae body length. This finding is consistent with a study that reported aromatase inhibitors (aminoglutethimide and 4-hydgoxyandrostenedione) and selective estrogen receptor modulator (tamoxifen and clomiphene) treatments decreased zebrafish larvae body length, and tamoxifen-mediated length decrements were rescued by E2 cotreatment (Hamad et al., 2007) . Many studies have shown the importance of steroid hormones, especially estrogen, in bone formation and growth, and subsequently, the need to mitigate osteoporosis risk associated with extended use of aromatase inhibitor therapeutics (Hant and Bolster, 2016) . In the larval zebrafish transcriptomic study previously mentioned, deactivation of apolipoprotein E (ApoE) pathway by BaP was suggested as a possible mechanism mediating decreased body size (Fang et al., 2015) . Accordingly, estradiol is a key element in activation of the ApoE pathway (Srivastava et al., 1997) . Future studies should investigate the effect of aromatase inhibition on the ApoE activity, receptor expression and the role of this pathway as an explanation for estrogen rescue of decreased body-length caused by BaP, fadrozole, and Cyp19a1b knockdown.
Deformity of tail shape, such as spinal curvature, is a common development alteration resulting from environmental contaminant exposure in fish (Noyes et al., 2015; Parrott and Bennie, 2009) . Similarly in humans, environmental factors, estrogen hormone reduction, and estrogen receptor polymorphisms are suggested as causes of idiopathic scoliosis (Esposito et al., 2009; Wang et al., 2011) . Here, we found that 50 mg/L BaP, fadrozole (10 and 50 mg/L), and Cyp19a1b knockdown significantly increased the incidence of abnormal tail shape as has been shown with fadrozole previously (Santos et al., 2014) . As with body length, E2 co-treatment significantly rescued the severe tail shape abnormality that was caused by 50 mg/L fadrozole and Cyp19a1b knockdown, and restored tail shape to normal control levels. Although 10 mg/L BaP decreased the incidence of normal tail shape from 90% in control to 70%, and normality was restored with E2 treatment, these impacts were not statistically significant suggesting that of the defects studied tail shape is not the most sensitive phenotype. At the high BaP dose, co-treatment with E2 did not rescue but instead enhanced tail shape deformity scores.
Decreased optic vesicle (eye) area (microphthalmia) was also observed in our studies. This negative effect could be due to dysfunctions in eye development or to the overall decreased body size previously discussed. BaP-waterborne exposure caused microphthalmia in rainbow trout alevins (Hose et al., 1984) . When considering eye development, it is possible to use morphological or cytochemical criteria to distinguish most retinal cell types and layers. A recent study found that BaP (2 lM; 504 mg/L) reduced cellular density in ganglion cell layer. Furthermore, these morphological changes were accompanied by differential expression of 15 genes involved in eye development and visual perception (Huang et al., 2014) . Studies with other AhR agonists including phenanthrene (Huang et al., 2013) and TCDD (Kim et al., 2013) have implicated the AhR-CYP1 pathways in ocular development and toxicity.
Aromatase inhibitors like aminoglutethimide also caused reductions in zebrafish larval eye diameter that was accompanied with decreased thicknesses of the retinal layers. Moreover, the selective estrogen receptor modulators tamoxifen and clomiphene decreased eye diameter, further supporting that estrogen and its receptors are important in eye development (Hamad et al., 2007) . Similar to the estrogen þ tamoxifen restoration of eye diameter noted by (Hamad et al., 2007) , E2 co-treatment with 10 mg/L BaP, both fadrozole concentrations and Cyp19a1b knockdown rescued the decreased larval eye areas. More studies are needed to clarify the interaction between AhR and ER pathways and their involvement in the eye development.
The fish swim bladder is believed to be evolutionarily similar to the mammalian lung (Zheng et al., 2011) . Development of the swim bladder in zebrafish starts as early as 48 hpf by formation of an epithelial bud that is followed by differentiation and growth that forms mesodermal layers (Winata et al., 2009) . After 72 hpf, the swim bladder of a zebrafish larva begins to inflate (Robertson et al., 2007) . This inflation can be a target of environmental contaminant exposure and is critical for larvae to decrease their body density and maintain neutral buoyancy to be able to capture food and escape predators . Endothelial cells and blood circulation are important in both the differentiation and inflation of the swim bladder (Winata et al., 2010) . In our study, non-inflated swim bladders were observed among BaP, fadrozole, E2-only treated and Cyp19a1b morphant larvae. Noninflated swim bladders were also reported in zebrafish offspring following a parental dietary exposure to BaP (Corrales et al., 2014) and in zebrafish embryos exposed to fadrozole (Santos et al., 2014) . Furthermore, the non-inflated swim bladder phenotype following 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl PCB126 exposure was AhR2 dependent, but was independent from cyp1 or cox signaling (Jonsson et al., 2012) . However, in fish exposed to PAH-and oxy-PAH contaminated soil extracts, incidence of non-inflated swim bladder was not definitively rescued by AhR2 knockdown (Wincent et al., 2015) . In our study, exogenous E2 treatment did not rescue the non-inflated swim bladder phenotype mediated by BaP exposure and Cyp19a1b knockdown. In larvae co-treated with either fadrozole concentration plus E2, there was an increased percentage of fish that had inflated swim bladders ($60%) compared to those exposed to fadrozole concentrations alone, but this percentage was still significantly lower than the control. Together these data suggest that E2 homeostasis is important in swim bladder formation and inflation. Some genes that play a role in development of swim bladder tissues include: nkccl, prl, shha, ihaa, ptc1, ptc2, fgf10a, and acta2 (Abbas and Whitfield, 2009; Li et al., 2011; Winata et al., 2009) . Future work analyzing promoter regions of these target genes for AhR and/or ERE response elements and measurement of potential BaP or E2-mediated differential expression of target genes may further resolve the adverse outcome pathway associated with the noninflated swim bladder phenotype. Also, work in the Heideman laboratory concluded that swim bladder development was arrested following developmental TCDD exposure as a downstream consequence of TCDD-mediated heart and circulatory failure (Yue et al., 2015) . Thus, the cardiac toxicities caused by BaP and aromatase inhibition may similarly be contributing to downstream swim bladder defects with the caveat that E2 cotreatment rescued cardiac edema in all three treatments but only rescued the uninflated swim bladders partially in the fadrozole co-treatments. Importantly, 10 nM E2 treatment alone caused significantly decreased swim bladder inflation, yet this was the only phenotype measured in our study in which E2 alone elicited a statistically significant difference from controls. Statistically significant pectoral fin deformities (e.g.; short or missing fin) were observed only in BaP exposed larvae. This finding is parallel with the multigenerational impact of dietary BaP on F1 and F2 pectoral fin formation (Corrales et al., 2014) and perturbation of pectoral fin development due to oxygenated PAHs exposure (Knecht et al., 2013) . Estradiol co-treatment did not rescue these fin morphological defects suggesting that BaP exposure disrupts larval pectoral fin development through pathways that are not associated with aromatase and E2-mediated pathways. Two genes, namely lama5 and skiv2l2, involved in fin development had down regulated exon usage in 96 hpf zebrafish larvae that were exposed prenatally and developmentally to BaP (Fang et al., 2015) . Lama5 encodes laminin alpha 5 protein that is involved in establishing and elongation of the apical fold (Webb et al., 2007) that emerges from the apical epidermal ridge and is critical for fin morphogenesis (Yano et al., 2012) . Further studies are needed to investigate the specific effects of BaP on laminin alpha 5 protein expression and potential linkages with human developmental defects.
CONCLUSION
Previous mechanistic studies in various laboratory model organisms have highlighted the role of AhR and Cyp1s in PAHmediated toxicities. However, this study was designed to compare the phenotypic defects caused by early life BaP exposure with adverse outcomes as a result of aromatase inhibition/ knockdown during development. All three aromatase inhibiting treatments reduced E2 concentrations by $50% in 48 hpf larvae. Estrogen replacement was able to counteract BaP, fadrozole, and Cyp19a1b knockdown-related phenotypes including increased mortality and pericardial edema, decreased body length and optic vesicle size. However, BaP-mediated phenotypes that were not rescued by E2 suggesting aromataseindependent mechanisms of action included abnormal tail shape and pectoral fin defects. Uninflated swim bladders were a consequence of all treatments including E2 treatment alone. Future molecular and developmental stage-specific work is necessary to test the interdependence and pathogenic sequela of the adverse outcomes across early development to determine for example if growth, hatch and mortality are all downstream consequences of BaP-mediated cardiac dysfunction. Nonetheless this study further highlights the developmental importance of estrogen homeostasis and highlights BaPmediated inhibition of aromatase as a key event in BaP's adverse developmental toxicities.
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